AU5408999A - Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound - Google Patents
Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compoundInfo
- Publication number
- AU5408999A AU5408999A AU54089/99A AU5408999A AU5408999A AU 5408999 A AU5408999 A AU 5408999A AU 54089/99 A AU54089/99 A AU 54089/99A AU 5408999 A AU5408999 A AU 5408999A AU 5408999 A AU5408999 A AU 5408999A
- Authority
- AU
- Australia
- Prior art keywords
- meiosis
- infertility
- camp
- treatment
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98250177 | 1998-05-26 | ||
EP98250177 | 1998-05-26 | ||
PCT/EP1999/003138 WO1999061010A2 (fr) | 1998-05-26 | 1999-05-07 | TRAITEMENT DE L'INFERTILITE PAR DES COMPOSES STIMULANT LA PRODUCTION D'AMPc, SEULS OU ASSOCIES A AU MOINS UN COMPOSE STIMULANT LA MEIOSE |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5408999A true AU5408999A (en) | 1999-12-13 |
Family
ID=8234594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU54089/99A Abandoned AU5408999A (en) | 1998-05-26 | 1999-05-07 | Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1098652A2 (fr) |
JP (1) | JP2002516272A (fr) |
KR (1) | KR20010043828A (fr) |
AU (1) | AU5408999A (fr) |
CA (1) | CA2333320A1 (fr) |
NO (1) | NO20005954D0 (fr) |
WO (1) | WO1999061010A2 (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001019354A2 (fr) | 1999-09-16 | 2001-03-22 | Novo Nordisk A/S | Composition pour fecondation in vitro |
US6544166B1 (en) | 1999-11-25 | 2003-04-08 | Groendahl Christian | Treatment of human infertility |
WO2001038493A1 (fr) * | 1999-11-25 | 2001-05-31 | Novo Nordisk A/S | Traitement de l'infertilite humaine |
AU2001240624A1 (en) * | 2000-02-25 | 2001-09-03 | Novo-Nordisk A/S | Improvement of implantation rate |
WO2001062260A2 (fr) * | 2000-02-25 | 2001-08-30 | Schering Aktiengesellschaft | Amelioration d'un taux d'implantation |
WO2001076360A2 (fr) * | 2000-04-06 | 2001-10-18 | Novo Nordisk A/S | Synchronisation de la maturation nucleaire et cytoplasmique d'oocytes in vitro |
EP1147774A1 (fr) | 2000-04-20 | 2001-10-24 | Stichting Dienst Landbouwkundig Onderzoek | Méthode d'amélioration de la qualité du sperme pour l'insémination artificielle des animaux |
JP2003533222A (ja) * | 2000-05-18 | 2003-11-11 | シエーリング アクチエンゲゼルシャフト | 経年卵母細胞の受精 |
EP1245572A1 (fr) | 2001-03-26 | 2002-10-02 | Schering Aktiengesellschaft | Composés aminostérols, leur utilisation pour la préparation des médicaments pour la régulation de la méiose et un procédé de leur préparation |
IL162506A0 (en) | 2001-12-14 | 2005-11-20 | Applied Research Systems | Ovulation induction |
WO2003070766A2 (fr) * | 2002-02-22 | 2003-08-28 | Novo Nordisk A/S | Transducteur de la signalisation de mas |
EP2750692B1 (fr) | 2011-08-30 | 2016-08-03 | Centre National De La Recherche Scientifique | Complexe protéinique comprenant des protéines mcm8 et mcm9 et leur utilisation |
GB201117453D0 (en) * | 2011-10-10 | 2011-11-23 | Univ Dundee | Improved sperm function/activity |
CN108531447B (zh) * | 2018-04-13 | 2021-11-23 | 上海市生物医药技术研究院 | 调节精子运动能力及辅助生殖的化合物及其用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0196530A3 (fr) * | 1985-03-26 | 1989-03-22 | CTA Finanz AG | Agent et procédé pour augmenter la croissance, optimiser la fécondité et stimuler le système immunitaire chez les humains et les animaux |
US5716777A (en) * | 1994-06-23 | 1998-02-10 | Novo Nordisk A/S | Regulation of meiosis using sterols |
KR19980702624A (ko) * | 1995-03-06 | 1998-08-05 | 슈타르 피아 | 감수분열의 자극 |
US5800625A (en) * | 1996-07-26 | 1998-09-01 | Cauldron Limited Partnership | Removal of material by radiation applied at an oblique angle |
CA2199663C (fr) * | 1997-03-11 | 2004-08-10 | Ruth Miriam Moses | Maturation et fecondation in vitro d'ovocytes mammaliens |
-
1999
- 1999-05-07 EP EP99939972A patent/EP1098652A2/fr not_active Withdrawn
- 1999-05-07 KR KR1020007013278A patent/KR20010043828A/ko not_active Application Discontinuation
- 1999-05-07 JP JP2000550470A patent/JP2002516272A/ja active Pending
- 1999-05-07 WO PCT/EP1999/003138 patent/WO1999061010A2/fr not_active Application Discontinuation
- 1999-05-07 AU AU54089/99A patent/AU5408999A/en not_active Abandoned
- 1999-05-07 CA CA002333320A patent/CA2333320A1/fr not_active Abandoned
-
2000
- 2000-11-24 NO NO20005954A patent/NO20005954D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1999061010A2 (fr) | 1999-12-02 |
WO1999061010A3 (fr) | 2000-04-27 |
KR20010043828A (ko) | 2001-05-25 |
JP2002516272A (ja) | 2002-06-04 |
NO20005954L (no) | 2000-11-24 |
EP1098652A2 (fr) | 2001-05-16 |
CA2333320A1 (fr) | 1999-12-02 |
NO20005954D0 (no) | 2000-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2951299A (en) | Disinfecting compositions and processes for disinfecting surfaces | |
AU7582398A (en) | Composition for treating skin conditions | |
AU2339699A (en) | Aqueous metal treatment composition | |
GB9821217D0 (en) | Treatment for substrates | |
AU1424200A (en) | Compounds | |
AU5408999A (en) | Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound | |
AU4501699A (en) | Aminoazole compounds | |
AU1772399A (en) | Well treatment | |
AU3123697A (en) | Angiostatic compounds | |
AUPP433398A0 (en) | Compounds and processes | |
AU1434500A (en) | Compounds | |
AU5056099A (en) | Compounds for use in the treatment of inflammation | |
AU1560200A (en) | Disinfecting agents | |
AU2656799A (en) | Metal-thiols as imminomodulating agents | |
AU7432698A (en) | Disinfectant composition | |
AU2333099A (en) | Aryloxyanilides and related compounds | |
GB9816252D0 (en) | Molluscicidal composition | |
AU1940800A (en) | Combination therapy for the treatment of sepsis | |
AU5757799A (en) | Weed-controlling agents | |
AU5056199A (en) | Molluscicidal composition | |
AU2641099A (en) | Imidazoquinazoline derivatives | |
AU2680200A (en) | Treating metal surfaces | |
AUPP375198A0 (en) | An anticorrosion treatment | |
AU2648899A (en) | Composition | |
AU5524399A (en) | Inorgasmia treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |